Oliver Zuehlke - Bayer Aktiengesellscha Insider

BAYRY -- USA Stock  

USD 29.02  0.18  0.62%

Member of the Supervisory Board

Mr. Oliver Zuehlke was Vice Chairman of the Supervisory Board and Employee Representative of Bayer Aktiengesellschaft since July 2015. He was Member of the Supervisory Board and Employee Representative at the Company from April 27, 2007. He is Member of the Presidial CommitteeMediation Committee, Audit Committee and Innovation Committee at the Company. He joined Bayer AG in Leverkusen, Germany, in 1985 and trained as a chemical production technician. During his training, in 1988, he became a member of the body representing young employees and apprentices. He chaired this body from 1990 to 1994. He was elected a fulltime member of the Works Council at the Leverkusen site in 1994 and was Deputy Chairman from 2002 to 2010. Since then, he has also been a member of the Economics Committee of Bayer AG. In 2009, he completed a distance learning course on human resources management. Between 2010 and 2015 he was Chairman of the Works Council at the Leverkusen site and also held various functions in the German Mining, Chemical and Power Workers Union . He was a member of the District Executive, the Regional Executive, the federal industrial group for the chemical industry, and the advisory board. From 2009 to 2015 Zuehlke was Chairman of the Bayer European Forum. In 2014 he became Member of the Supervisory Board of Bayer Pharma AG. Since 2015 he was Chairman of the Central Works Council of Bayer AG.
Age: 48  Executive Since 2015      
49 214 30 1  http://www.bayer.com
Zuehlke is Chairman of the Works Council of the Leverkusen site of Bayer AG and is Chairman of the Bayer European Forum. He is Member of the Supervisory Board at Bayer Pharma AG since May, 2014. He is Member of the Human Resources Committee at the Company.

Management Efficiency

The company has return on total asset (ROA) of 5.22 % which means that it generated profit of $5.22 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 9.39 % meaning that it generated $9.39 on every $100 dollars invested by stockholders.
The company has accumulated 16.52 B in total debt with debt to equity ratio (D/E) of 36.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bayer Aktiengesellschaft has Current Ratio of 2.48 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 3 records


David StarkTeva Pharmaceutical Industries
Timothy WrightTeva Pharmaceutical Industries
Soumendra DasSJVN Limited

Entity Summary

Bayer Aktiengesellschaft operates as a life science company worldwide. The company was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktiengesellscha is traded on OTC Market in USA.Bayer Aktiengesellschaft (BAYRY) is traded on OTC Market in USA. It is located in Kaiser-Wilhelm-Allee 1 and employs 100,110 people.

Bayer Aktiengesellschaft Leadership Team

Jennifer Brendelto, President
Heike Hausfeld, Executive
Peter Hausmann, Executive
Heiko Schipper, Executive
Thomas Fischer, Executive
Marijn Dekkers, Chairman
Detlef Rennings, Executive
Helmut Panke, Executive, Ph.D
Werner Wenning, Chairman
Reiner Hoffmann, Executive
Sue Rataj, Executive, MBA
Petra ReinboldKnape, Executive
Dieter Weinand, Executive
Werner Baumann, Executive
Kemal Malik, Executive, Ph.D
Petra Kronen, Executive
Oliver Zuehlke, Executive
Thomas Elsner, Executive, Ph.D
Alexander Rosar, Executive
Simone BagelTrah, Executive, Ph.D
Michael SchmidtKiessling, Executive
ErnstLudwig Winnacker, Executive
Colleen Goggins, Executive
Heinz Webers, Executive
Johanna Faber, Executive, MBA
Paul Achleitner, Executive, Ph.D
Klaus Sturany, Executive, Ph.D
Frank Loellgen, Executive
Andre Broich, Executive
Liam Condon, CEO
Patrick Thomas, CEO
Yueksel Karaaslan, Executive
Thomas Ebeling, Executive
Erica Mann, Executive
Norbert Bischofberger, Executive, Ph.D
Johannes Dietsch, CFO
Hartmut Klusik, Director, Ph.D
Michael Koenig, Executive
Clemens Boersig, Executive, Ph.D
Juergen Beunink, Executive
Thomas Win, Chairman
Otmar Wiestler, Executive, Ph.D
Sabine Schaab, Executive
Wolfgang Plischke, Executive, Ph.D

Stock Performance Indicators

Current Sentiment - BAYRY

Bayer Aktiengesellschaft Investor Sentiment
Most of Macroaxis users are currently bullish on Bayer Aktiengesellschaft. What is your opinion about investing in Bayer Aktiengesellschaft? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Bayer Aktiengesellscha and SJVN Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.